Aerie Pharmaceuticals announced the submission of its New Drug Application (NDA) to the FDA for Rhopressa (netarsudil ophthalmic solution) 0.02%....
Aclaris Therapeutics, Inc. announced positive results from its Phase III clinical trial, THWART-2 (WART-302), of A-101 45% Topical Solution (A-101...
Treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients (see section 4.2). Treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Santen Pharmaceutical Co., Ltd. announced that it has obtained manufacturing and marketing approval for the dry eye treatment Diquas LX Ophthalmic Solution 3% (diquafosol sodium) in Japan.